Black Stone Minerals (BSM) FY 2025 Annual General Meeting June 12, 2025 01:00 PM ET Speaker0 Hello and welcome to the Blackstone Minerals twenty twenty five Annual Meeting of Limited Partners. Please note that this meeting is being recorded. Questions may be submitted via the message icon at the top left of your screen by typing your message then clicking the send icon to the right of the message box. The meeting is about to begin. Speaker1 Good afternoon, ladies and gentlemen. It's now 12PM. And in accorda ...

Intellia Therapeutics (NTLA) FY 2025 Annual General Meeting June 11, 2025 09:00 AM ET Speaker0 Good day, and welcome to the Intellia Therapeutics Incorporated twenty twenty five Annual Meeting of Stockholders. I would now like to turn the conference over to Doctor. Frank Furweil, Chairperson of the company's Board of Directors, to proceed with the twenty twenty five Annual Meeting of Stockholders. Doctor. Verwil, please go ahead. Speaker1 Thank you. Good morning. I'm Doctor. Frank Verwil, Chairperson of the ...

Financial Data and Key Metrics Changes - All 11 director nominees have been elected, indicating strong shareholder support for the board [7] - Stockholders approved the advisory compensation of Expedia Group's named executive officers, reflecting confidence in management [8] - Ernst and Young has been ratified as the independent registered public accounting firm for fiscal year 2025, ensuring continued oversight [8] Business Line Data and Key Metrics Changes - No specific business line data or key metrics were provided in the meeting Market Data and Key Metrics Changes - No specific market data or key metrics were provided in the meeting Company Strategy and Development Direction and Industry Competition - The compensation committee considers various factors in establishing executive officer compensation, including business performance and competitive market data, which indicates a strategic focus on aligning executive pay with company performance [10] Management's Comments on Operating Environment and Future Outlook - Management did not provide specific comments on the operating environment or future outlook during the meeting Other Important Information - The meeting was conducted in accordance with Delaware General Corporation Law and the company's bylaws, ensuring compliance and proper governance [7] Q&A Session Summary Question: Regarding the compensation committee's use of the SEC's compensation metric - The compensation committee does not rely specifically on the SEC's compensation metric but reviews various factors including prior year performance and competitive compensation data when setting executive compensation [9][10]

Tile Shop (TTSH) FY 2025 Annual General Meeting June 03, 2025 11:00 AM ET Speaker0 Thank you for standing by, and welcome to the Tile Shop Holdings, Inc. Annual meeting. I will now turn the meeting over to Peter Kamen. Please go ahead. Speaker1 Good morning, ladies and gentlemen. The twenty twenty five Annual Meeting of the Stockholders of Tile Shop Holdings is now called to order. I would like to extend a welcome to any stockholders attending this virtual annual meeting. Stockholders may submit questions a ...

Financial Data and Key Metrics Changes - The company held its Annual General Meeting on May 29, 2025, with a quorum present for voting on various proposals [4][14] - The appointment of Witham Smith and Brown, PC as the independent registered public accounting firm for fiscal year 2025 was ratified [14] Business Line Data and Key Metrics Changes - No specific financial data or metrics related to individual business lines were discussed in the meeting [1][15] Market Data and Key Metrics Changes - No specific market data or metrics were provided during the meeting [1][15] Company Strategy and Development Direction and Industry Competition - The meeting included proposals for the election of directors and advisory votes on executive compensation, indicating a focus on governance and shareholder engagement [6][10] - The company values stockholder opinions on executive compensation and the frequency of advisory votes, reflecting a commitment to transparency and accountability [11][14] Management's Comments on Operating Environment and Future Outlook - Management did not provide specific comments on the operating environment or future outlook during this meeting [1][15] Other Important Information - The meeting included a nonbinding advisory vote on executive compensation and the frequency of future advisory votes, emphasizing the company's approach to governance [10][11] - The final results of the votes will be published in a Form 8-K filed with the SEC within four business days [14] Q&A Session All Questions and Answers - No questions were raised during the meeting regarding the proposals or other matters [13][15]

Financial Data and Key Metrics Changes - The meeting confirmed the election of two class one directors and the ratification of KPMG as the independent registered public accounting firm for the fiscal year ending December 31, 2025 [5][13]. Business Lines Data and Key Metrics Changes - No specific data or metrics related to individual business lines were discussed in the meeting [1]. Market Data and Key Metrics Changes - No specific market data or metrics were provided during the meeting [1]. Company Strategy and Development Direction and Industry Competition - The company is focused on maintaining strong governance by electing qualified directors and ensuring reliable financial oversight through the appointment of KPMG [5][13]. Management's Comments on Operating Environment and Future Outlook - Management did not provide specific comments on the operating environment or future outlook during this meeting [1]. Other Important Information - The meeting was conducted virtually, and a sufficient number of shares were present to constitute a quorum [3][4]. Summary of Q&A Session - There were no questions or comments from attendees during the Q&A session [7].

Intensity Therapeutics (INTS) FY 2024 Annual General Meeting July 17, 2024 10:00 AM ET Speaker0 Thank you for standing by, and welcome to the twenty twenty four Annual Meeting of Stockholders of Intensity Therapeutics Inc. I'd now like to turn the meeting over to Louis H. Bender, President, Chief Executive Officer, and Chairman of the company. You may begin. Speaker1 Well, thank you, Rob, and good morning. Welcome to the twenty twenty four annual meeting of stockholders of Intensity Therapeutics Incorporate ...